Bilastine - CAS# 202189-78-4 enzyl)-N2 N2-dimethyl-N1-(pyridin-2-yl)ethane-1 2-diamine hydrochloride Cariprazine is approved for schizophrenia

Cariprazine is approved for schizophrenia and bipolar disorder

It is also found that IC87114 (5 µM–30 µM) inhibits SCF- or IL-3-stimulated BMMC responses

Chemical Name: 2-Bromo-4-[(6

also known as G-868

Chemical Name: ethyl 2-(4-chlorophenoxy)-2-methylpropanoate

Bilastine - CAS# 202189-78-4 enzyl)-N2 N2-dimethyl-N1-(pyridin-2-yl)ethane-1 2-diamine hydrochloride Cariprazine is approved for schizophreniaBilastine (trade name Bilaxten) is a second generation antihistamine drug for the treatment of allergic rhinoconjunctivitis and urticaria (hives). It exerts its effect as a selective histamine H1 receptor antagonist, and has a potency similar to cetirizine and is superior to fexofenadine. It was developed in Spain by FAES Farma. Bilastine is approved in the European Union for the symptomatic treatment of allergic rhinoconjunctivitis and urticaria, but